On June 5, 2025, TAG and WHO cohosted a webinar orienting people to long-acting injectables for TB treatment and prevention. Long-acting Injectables (LAIs) have the potential to revolutionize treatment for TB and other infectious diseases.
This webinar will provide a platform to learn about the findings from the Longevity HCV and TB end users and healthcare providers/policy makers surveys, and for community members, especially marginalized populations across the world, to engage with the researchers developing these Long-Acting Therapies.
TAG, APCASO, and Diagnostics Equity Consortium (DEC) hosted a two-part webinar series exploring the evolving TB diagnostic landscape and strategies to increase TB testing coverage, with a specific focus on the South-East Asia and Western-Pacific regions.
The 2025 Pre-CROI Community HIV Cure Research Workshop will take place on Saturday, March 8 in San Francisco.
To help advocates stay up to date, Treatment Action Group (TAG) organized a series of virtual trainings on the diagnosis, treatment, care and support of people with drug-resistant TB, designed for community and civil society organizations.
On May 15, 2024, TAG hosted this webinar on the TB Diagnostics Pipeline: New Tools & Opportunities to Improve Access to Testing.
TAG hosted this May 31 webinar on the growing pipeline of microarray patches (MAPs) for various infectious diseases treatment and immunization.
On May 7 and 21, TAG celebrated Pride season by hosting for an essential webinar that addressed the unique health concerns of the LGBTQ+ community, focusing on engaging LGBTQ patients.
On March 27, 2024, the 1/4/6x24 Campaign and the Stop TB Partnership co-hosted a webinar to launch the Campaign’s new report: Getting Better Faster: Delivering on the Promise of New TB Treatments.
On March 26, 2024, TAG presented this webinar that discusses implementing long-lasting injectable PrEP treatments and the evolving landscape of HIV prevention.